Pure Global
NCT05285345

Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease

Boston Children's Hospital·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Bronchopulmonary Dysplasia
Study type
Observational
Sponsor & location
Primary sponsor
Boston Children's Hospital
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2022
End date
Nov 01, 2023
Enrollment
50 participants
Primary outcome

Healthcare Utilization

Summary

The researchers have worked to create consensus recommendations among national efforts to
 help with the transition and coordination of care for preterm infants with lung disease
 around discharge from the neonatal intensive care unit to home. This study looks to evaluate
 implementation of the recommendations at Boston Children's Hospital and referring NICU's
 (Beth Israel Deaconess Medical Center and Brigham and Women's Hospital). Specifically, the
 research team will be looking at follow-up rates, healthcare utilization, and parental
 satisfaction/feedback with implementation of these guidelines.

ICD-10 classifications
Bronchopulmonary dysplasia originating in the perinatal periodCongenital bronchomalaciaBronchopneumonia, unspecifiedOther congenital malformations of bronchusDiseases of bronchus, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05285345
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05285345 through Pure Global AI's free database. This phase not specified trial is sponsored by Boston Children's Hospital and is currently Not yet recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.